LOTTE to Purchase East Syracuse, New York BMS Manufacturing Facility

Update : 13th May, 2022

Korean-based LOTTE have announced that they will take over Bristol Myers Squibb’s manufacturing facility in East Syracuse, New York. The facility will become LOTTE’s centre of North American Operations of their CDMO business. LOTTE will take over the plant, property, equipment and workforce. 

“We are pleased to add this state-of-the-art facility to our global pharma operations, which will enable us to rapidly scale and expand our biologics CDMO business in North America. We look forward to welcoming the talented team in East Syracuse to LOTTE, and we intend to make significant investments to further enhance the facility and its capabilities to support our strategic growth objectives moving forward.” - Hunki Lee, Executive Vice President of LOTTE Corporation.
Karin Shanahan, BMS Executive Vice President of Global Product Development and Supply had this to say: “The East Syracuse site has been an important part of our company’s history and our manufacturing network for many decades, and we are confident that LOTTE will fully leverage the facility, its capabilities and its experienced workforce as it continues to play a vital role for patients around the world … We have taken a thoughtful approach to this decision and are confident this will best support the continued evolution of our manufacturing network and our mission to deliver innovative medicines that help patients prevail over serious diseases.”

Source : Bristol Myers Squibb


This news article complies with our Editorial Policy